Relay Therapeutics, Inc. (RLAY)
8.03
+0.24
(+3.08%)
USD |
NASDAQ |
Dec 12, 16:00
8.17
+0.14
(+1.74%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly): -0.4301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Lantheus Holdings, Inc. | 0.4104 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Insmed, Inc. | -1.747 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.15M |
| Total Expenses (Quarterly) | 74.15M |
| Enterprise Value | 828.68M |
| Earnings Yield | -21.80% |
| Normalized Earnings Yield | -21.80 |